Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lesko

Showing results (191-200 of 231) with videos related to

Pageof 24
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|September 28, 2018
Establishing a Multidisciplinary Framework to Study Drug-Drug Interactions of Hormonal Contraceptives: An Invitation to CollaborateLawrence J Lesko, Valvanera Vozmediano, Joshua D Brown, et al.
British Journal of Haematology|July 1, 1985
Cyclical neutropenia and T8 lymphocyte mediated stimulation of granulopoiesisJ G Smith, A K Seenan, M A Smith, et al.
Prenatal Diagnosis|February 1, 1996
Clinical experience with preimplantation genetic diagnosis of cystic fibrosis (delta F508)A Ao, P Ray, J Harper, et al.
Pharmaceutical Development and Technology|December 3, 1998
Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tabletsN D Eddington, M Ashraf, L L Augsburger, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 5, 2002
Variability in cimetidine absorption and plasma double peaks following oral administration in the fasted state in humans: correlation with antral gastric motilityNarushi Takamatsu, Lynda S Welage, Yayoi Hayashi, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 15, 2021
Physiologically-based pharmacokinetics modeling to investigate formulation factors influencing the generic substitution of dabigatran etexilateNashid Farhan, Rodrigo Cristofoletti, Sumit Basu, et al.
Therapeutic Drug Monitoring|July 18, 2015
Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin TherapyKaitlyn Shaw, Ursula Amstutz, Richard B Kim, et al.
Pharmacogenomics|December 24, 2008
Fit-for-purpose pharmacogenomic biomarkers in drug development: a project team case study with 'what-ifs'Linda C Surh, Lawrence J Lesko, Stuart Hobbs, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|June 7, 2017
Evaluation of the Potential for Drug Interactions With Patiromer in Healthy VolunteersLawrence J Lesko, Elliot Offman, Christine Taylor Brew, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 7, 2000
Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humansL J Lesko, M Rowland, C C Peck, et al.
Pageof 24

Showing results (191-200 of 231) with videos related to

Sort By:
Pageof 24
CPT: Pharmacometrics & Systems Pharmacology|September 28, 2018
Establishing a Multidisciplinary Framework to Study Drug-Drug Interactions of Hormonal Contraceptives: An Invitation to CollaborateLawrence J Lesko, Valvanera Vozmediano, Joshua D Brown, et al.
British Journal of Haematology|July 1, 1985
Cyclical neutropenia and T8 lymphocyte mediated stimulation of granulopoiesisJ G Smith, A K Seenan, M A Smith, et al.
Prenatal Diagnosis|February 1, 1996
Clinical experience with preimplantation genetic diagnosis of cystic fibrosis (delta F508)A Ao, P Ray, J Harper, et al.
Pharmaceutical Development and Technology|December 3, 1998
Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tabletsN D Eddington, M Ashraf, L L Augsburger, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 5, 2002
Variability in cimetidine absorption and plasma double peaks following oral administration in the fasted state in humans: correlation with antral gastric motilityNarushi Takamatsu, Lynda S Welage, Yayoi Hayashi, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 15, 2021
Physiologically-based pharmacokinetics modeling to investigate formulation factors influencing the generic substitution of dabigatran etexilateNashid Farhan, Rodrigo Cristofoletti, Sumit Basu, et al.
Therapeutic Drug Monitoring|July 18, 2015
Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin TherapyKaitlyn Shaw, Ursula Amstutz, Richard B Kim, et al.
Pharmacogenomics|December 24, 2008
Fit-for-purpose pharmacogenomic biomarkers in drug development: a project team case study with 'what-ifs'Linda C Surh, Lawrence J Lesko, Stuart Hobbs, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|June 7, 2017
Evaluation of the Potential for Drug Interactions With Patiromer in Healthy VolunteersLawrence J Lesko, Elliot Offman, Christine Taylor Brew, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 7, 2000
Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humansL J Lesko, M Rowland, C C Peck, et al.
Pageof 24